pressure (MEP). MIP is the maximum negative pressure that can be generated from one inspiratory effort starting from functional residual capacity (FRC) or residual volume (RV). MEP measures the maximum positive pressure that can be generated from one expiratory effort starting from total lung capacity (TLC) or FRC.
This study aimed to measure the respiratory muscle strength using MIP and MEP in clinically stable male COPD patients, to determine the correlates for MIP and MEP, and to study the relationship between severity of COPD (GOLD Criteria) and respiratory muscle strength.
PatIents and Methods
This was a cross-sectional, observational study. Convenience sampling was used. Participation was purely on voluntary basis. After obtaining informed consent, 100 males, who were known COPD patients, both inpatients and outpatients, and who were clinically stable, were recruited. Ethical clearance was obtained from the Ethical Review Board of the Institution. This study was conducted on male patients only to avoid intergender differences in MIP and MEP. A total of 99 patients completed the MIP and MEP assessment phase. There was a dropout of one patient due to noncompliance and thus incomplete data.
Patients with primary muscular/neuromuscular diseases and clinically significant comorbidities that could affect the test results and COPD patients in acute exacerbation were excluded from the study.
For all patients, demographic data were obtained. Spirometric pulmonary function (PFT) was done using Schiller machine. Best of the three successive test readings were taken as a final result, and the primary values, i.e., forced vital capacity (FVC), forced expiratory volume in the 1 s (FEV 1 ), and FEV 1 /FVC ratios were recorded. Anthropometry was done by measuring weight in kilogram (kg) and height with a stadiometer and body mass index (BMI) was calculated according to the formula kg/m 2 . MIP and MEP were determined using portable pressure meter (Micro respiratory pressure meter). MIP was measured from FRC or RV, and MEP was measured starting from TLC. All recordings were taken in the sitting posture. Maximum of three trials were given with an interval of 1 min between the trials for each subject. The highest value was accepted for computation.
The collected data were coded, tabulated, and introduced to PC using SPSS 16 (SPSS Inc., SPSS for Windows, Chicago). Descriptive statistics were used to obtain mean and standard deviation (±SD) for parametric numerical data, namely, age, height, weight, BMI, FEV 1 , FVC, FEV I /FVC, MIP, and MEP. Pearson's correlation was used to assess the relation between MIP and MEP with independent variables such as age, height, weight, BMI, FEV 1 %, FVC%, and FEV I /FVC%.
results
A total of 99 known COPD male patients, who were clinically stable, completed the measurement process in this study. The mean age of the COPD population studied was 62.90 ± 6.23 years. PFT measured by spirometry showed a mean (±SD) FEV 1 % of 47.81 ± 23.9, mean (±SD) FVC% of 63.99 ± 22.08, and mean (±SD) FEV 1 /FVC% of 67.60 ± 21.99. Maximum inspiratory and expiratory pressures were a mean (±SD) 47.73 ± 19.6 and 60.76 ± 11.6 cm H 2 O, respectively, [ Table 1 ].
Pearson's correlation-coefficient was used to assess the relation between MIP and MEP with independent variables such as age, height, weight, BMI, FEV 1 %, FVC%, and FEV I /FVC% [ Tables 2 and 3 ]. It was seen that MIP showed a highly significant correlation (P < 0.001) with both FEV 1 % and FVC%. The correlation between MIP and FEV 1 shows a positive linear trend and more clustering of MIP toward FEV 1 at 25%-75% [ Figure 1 ]. MEP showed a highly significant correlation (P < 0.001) with weight, FEV 1 %, and FVC% and a moderately significant correlation (P < 0.05) with BMI [ Table 3 ].
A positive linear correlation was seen between MEP and FEV 1 , and the MEP P values were higher than MIP P values [ Figure 2 ]. A negative correlation existed between MIP and MEP with age [ Figures 3 and 4 ]. With increase in age, there was a decrease in both MIP and MEP. According to the value of FEV 1 %, the results revealed that 30% of COPD patients had very severe airflow obstruction (FEV 1 <30%), 35% had severe airflow obstruction (FEV 1 30%-50%), 25% had moderate airflow obstruction (FEV 1 50%-80%), and 9% of patients had mild airflow obstruction (FEV 1 >80%) [ Table 4 ].
As the severity of airflow obstruction is progressively increasing, the value of MIP and MEP were significantly lowered in patients with severe and very severe airway obstruction with a statistically significant difference between the levels of airway obstruction concerning MIP value (F-test-29.31, P < 0.001) and MEP value (F-test-15.67, P < 0.001) [ Table 5 ].
It is seen from the box and error plot that there was a decrease in MIP and MEP with increasing severity of COPD [ Figures 5 and 6 ]. There is a positive correlation between MIP and MEP [ Figure 7 ].
dIscussIon
The results show that the MIP values among male COPD patients were much lower than their age-matched controls. [12] The MIP (inspiratory muscle strength) values were more affected when compared to MEP (expiratory muscle strength) MIP and MEP correlated with FEV 1 , i.e., when FEV 1 reduced, MIP and MEP also reduced significantly. The results obtained in the present study were in parallel with some of the recent literature. In addition, it was seen that respiratory muscle weakness occurs early in COPD with a decline in MIP and MEP as the severity of the disease (GOLD Criteria) progressed. The results show that the MIP values among COPD patients were much lower than their age-matched normal people. However, the MEP values did not show much of a difference in the (60-70) years of age group. The MIP (inspiratory muscle strength) values were more affected when compared to MEP (expiratory muscle strength) values in COPD patients. According to a study done by Voicu et al., MIP was significantly decreased in moderate to severe stages of COPD which correlated with decreased effort capacity as measured by 6-min walk distance.
The lean body mass decreases with increase in the severity of the disease. Thus, there is decreased muscle strength which is induced by various factors such as oxidative stress, inflammatory status, metabolic and nutritional dysfunction, bed rest, and prolonged steroid treatment. [13] MIP and MEP indicate the state of respiratory muscle strength and is related to the severity of COPD and spirometric indices.
MIP negatively correlated with age. Due to the aging process, there is a reduction in the diaphragm and respiratory muscle mass. Therefore, MIP was further compromised in COPD patients. [14] Khalil et al. studied MIP and MEP in patients with COPD being 43.6% ± 26.9% and 46.8% ± 26%, respectively, which was similar to this present study. [15] It was concluded in a study done by Hans-Joachim Kabitz that inspiratory muscle strength decreases in COPD patients with increasing disease severity. This could be attributed to two factors: compromised diaphragmatic contractility in the early stages and further reduction in inspiratory muscle strength following hyperinflation in advanced COPD. All these lead to decreased exercise capacity, impaired gas exchange, and increased dyspnea. Thus, the two mechanisms responsible for decreased MIP in COPD are decreased diaphragmatic contractility which begins in the early stages of the disease, which is independent of hyperinflation, and second, decreased diaphragmatic force generation due to hyperinflation in severe to very severe stages of the disease. [16] 
Limitations of the study
In this study, other factors, such as smoking, medication compliance, and comorbidities were not considered, which probably could have an influence on MIP and MEP.
conclusIon
COPD is a cause of respiratory muscle weakness and it occurs early in the disease. There is a decrease in respiratory muscle strength, especially inspiratory muscle strength (MIP) with progression of the disease. 
Conflicts of interest
There are no conflicts of interest.
references

